Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,157 | 15,120 | 15,428 | 17,703 | 13,806 |
| Receivables | 127,355 | 123,068 | 115,103 | 106,741 | 92,867 |
| Inventories | 59,402 | 71,702 | 60,445 | 45,443 | 38,151 |
| Other current assets | 10,516 | 5,093 | 5,061 | 5,109 | 6,227 |
| TOTAL | $226,606 | $223,136 | $211,702 | $189,055 | $165,848 |
| Non-Current Assets | |||||
| PPE Net | 97,063 | 99,626 | 105,028 | 110,952 | 115,293 |
| Intangibles | 105,848 | 106,371 | 106,928 | 107,584 | 108,028 |
| Other Non-Current Assets | 160,889 | 157,262 | 154,696 | 173,262 | 179,410 |
| TOTAL | $363,800 | $363,259 | $366,652 | $391,798 | $402,731 |
| Total Assets | $590,406 | $586,395 | $578,354 | $580,853 | $568,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,549 | 33,506 | 45,847 | 29,726 | 23,028 |
| Accrued Expenses | 22,901 | 18,791 | 23,431 | 20,833 | 26,526 |
| Other current liabilities | 8,157 | 7,651 | 8,360 | 7,683 | 8,399 |
| TOTAL | $97,586 | $88,097 | $103,135 | $90,782 | $89,750 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,111 | 163,134 | 172,386 | 188,636 | 259,433 |
| Deferred Revenues | 9,332 | 4,755 | 5,942 | 7,765 | 5,457 |
| Other Non-Current Liabilities | 94,437 | 92,310 | 90,797 | 115,606 | 123,098 |
| TOTAL | $235,084 | $268,491 | $286,265 | $329,070 | $403,256 |
| Total Liabilities | $332,670 | $356,588 | $389,400 | $419,852 | $493,006 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,827 | 46,857 | 46,634 | 46,277 | 44,574 |
| Common Shares | 470 | 469 | 1,194 | 1,188 | 1,148 |
| Retained earnings | 150,280 | 120,756 | 85,949 | 68,349 | 50,456 |
| Other shareholders' equity | 439 | -429 | 557 | -5,656 | -3,215 |
| TOTAL | $257,736 | $229,807 | $188,954 | $161,001 | $75,573 |
| Total Liabilities And Equity | $590,406 | $586,395 | $578,354 | $580,853 | $568,579 |